Takeda Pharmaceutical TAK
NYSE TAK
$18.19 -0.33 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Market Capitalization (2018 - 2026)

Updated

Takeda Pharmaceutical (TAK) reported Market Capitalization of $2.32 billion for the quarter ended Jun 30, 2026, up 3.7% from $2.24 billion a year earlier but down 13.4% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Market Capitalization (2018 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Takeda Pharmaceutical posted Market Capitalization of $2.68 billion, up 24.6% from the prior year.

  • Market Capitalization has a five-year compound annual growth rate of 0.5% (years ended Mar 2021 to Mar 2026).
  • By year, Market Capitalization came in at $2.15 billion in the year ended Mar 31, 2025 (+7.6%), $2 billion in the year ended Mar 31, 2024 (-15.7%), $2.37 billion in the year ended Mar 31, 2023 (+15.1%) and $2.06 billion in the year ended Mar 31, 2022 (-21.3%).
  • Five-year quarterly Market Capitalization spans a low of $1.86 billion in the quarter ended Jun 30, 2024 and a high of $2.68 billion in the quarter ended Mar 31, 2026.
  • Year over year, Market Capitalization has now increased in each of the last six quarters, with growth averaging 7.8% over the last eight quarters.
  • The high point for year-over-year Market Capitalization in five years was the quarter ended Mar 31, 2026 (growth of 24.6%); the low point was the quarter ended Mar 31, 2022 (a decline of 21.3%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $2.68 billion (quarter ended Mar 31, 2026), $2.25 billion (quarter ended Dec 31, 2025) and $2.12 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.32 Bn
Mar 31, 2026 2.68 Bn
Dec 31, 2025 2.25 Bn
Sep 30, 2025 2.12 Bn
Jun 30, 2025 2.24 Bn
Mar 31, 2025 2.15 Bn
Dec 31, 2024 1.90 Bn
Sep 30, 2024 2.05 Bn
Jun 30, 2024 1.86 Bn
Mar 31, 2024 2.00 Bn
Dec 31, 2023 2.05 Bn
Sep 30, 2023 2.23 Bn
Jun 30, 2023 2.26 Bn
Mar 31, 2023 2.37 Bn
Dec 31, 2022 2.24 Bn
Sep 30, 2022 1.87 Bn
Jun 30, 2022 2.02 Bn
Mar 31, 2022 2.06 Bn
Jun 30, 2021 2.41 Bn
Mar 31, 2021 2.62 Bn
API Access

Takeda Pharmaceutical Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=TAK&period=max&api_key=YOUR_API_KEY